ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

For NCI ; Scharff Succeeds Eagle At Einstein

September 25, 1987

Clinton’s FY97 Budget Sees $12.4 Billion For NIH, $2.28B For NCI

March 22, 1996

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure

August 12, 1988

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000

NCI Cancer Studies In China Intact; Visits Delayed

July 14, 1989